Search results
Fundamental Principles. Treat patients based on clinical suspicion as soon as possible, preferably within the first 5 days of symptoms. Perform PCR testing, but do not withhold treatment pending results.
25 lis 2021 · Treatment with hydroxychloroquine (HCQ), zinc, and azithromycin (AZM), also known as the Zelenko protocol, and treatment with intravenous (IV) vitamin C (IVC) have shown encouraging results in a large number of trials worldwide.
%PDF-1.6 %âãÏÓ 3976 0 obj > endobj 3983 0 obj >/Filter/FlateDecode/ID[3BF39A5F84E94B5FA8126AB9059C810E>6F4EFC493E2E4B3BBB0209F3A4EE3CFC>]/Index[3976 14]/Info 3975 ...
29 cze 2022 · Methods: We conducted an open-labeled, randomized, controlled trial to compare the efficacy between a 3-day course of once-daily high-dose oral ivermectin plus zinc sulfate (Group A) and a combination of HQ, darunavir/ritonavir, and zinc sulfate (HQ + antiretroviral, Group B) for 5 days in asymptomatic or mild SARS-CoV-2 infection. The study ...
17 cze 2021 · A concentration dependent antiviral effect of ivermectin in COVID-19 was identified, with significant reductions in SARS-CoV-2 viral load in respiratory secretions among patients achieving high systemic ivermectin concentration compared to untreated controls.
On the Zelenko protocol: The road not taken. Dr. Vladimir Zev Zelenko proposed an early outpatient treatment for the SARS-CoV-2 pandemic in two letters dated March 24, 2020 and April 28, 2020, that were then followed up with a research publication dated December 2020.
The Zelenko concept: Treat early to prevent the virus from spreading to the lungs and to other vital organs and stop the progression of the disease. Outcomes were reported in a follow-up letter dated April 28, 2020: 1450 patients were seen 405 were risk-stratified in the high risk category and treated with the triple-drug therapy
